netbiz

About netbiz

This author has not yet filled in any details.
So far netbiz has created 34 blog entries.

OrSense Ltd.

OrSense detects hemorrhage, anemia during pregnancy
Israel’s OrSense , a developer of monitors for non-invasive measurements of various blood parameters, announced successful clinical trial results for anemia screening and hemorrhage detection via non-invasive methods. Dr. Eran Hadar, of the Department of Maternal Fetal Medicine at Rabin Medical Center, said OrSenes’s NBM200 device was as accurate as

Gamida Cell Ltd.

The Gamida Cell-Teva Joint Venture Concludes Enrollment for the Phase III Study of StemEx®, a Cord Blood Stem Cell Product, for Leukemia and Lymphoma. The results of the StemEx study are expected during the second half of 2012
Jerusalem, Israel, February 13, 2012 — Gamida Cell announced today that the Gamida Cell-Teva Joint Venture (JV), equally

D-Pharm Ltd.

D-Pharm announces expected date of interim report for the DP-b99 Acute Ischemic Stroke Study, MACSI
D-Pharm Ltd., (TASE: DPRM) announced today that the interim report for the DP-b99 MACSI study is expected in February, 2012. The report will be based on the futility analysis of the data obtained from first 350 patients that complete the follow

OrSense Ltd.

OrSense’s Non-Invasive Hemoglobin Measurement System for Pre-Donation Screening of Anemia Delivers Superior Clinical Value Compared to Current MethodsRepresentatives of three hospitals and Red Cross blood donation centers will present data on OrSense’s non-invasive hemoglobin screening system at AABB
NES ZIONA, Israel, Oct 20, 2011  — OrSense Ltd., developer of monitors for non-invasive measurements of various blood